Ingalls & Snyder LLC’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Ingalls & Snyder LLC’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-758,055	Closed	-$12.8M	–	395
2014 Q4	$12.8M	Sell	758,055 -2,248,627	-75%	-$31.6M	0.75%	34
2014 Q3	$35.8M	Sell	3,006,682 -7,287,461	-71%	-$49.8M	1.93%	6
2014 Q2	$58.1M	Sell	10,294,143 -790,300	-7%	-$3.64M	2.85%	4
2014 Q1	$40.7M	Sell	11,084,443 -86,448	-0.8%	-$329K	2.18%	5
2013 Q4	$37.5M	Buy	11,170,891 +16,190	+0.1%	+$66.9K	2.07%	7
2013 Q3	$47.2M	Sell	11,154,701 -65,179	-0.6%	-$309K	2.82%	4
2013 Q2	$51.6M	Buy	+11,219,880	New	+$38.6M	3.29%	4

Ingalls & Snyder LLC's AVNR Position: Q1 2015 in Review

Ingalls & Snyder LLC sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 758,055 shares — an estimated $12.8M sold.

Ingalls & Snyder LLC first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $58.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Ingalls & Snyder LLC reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Ingalls & Snyder LLC sold 758,055 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $12.8M.
Ingalls & Snyder LLC first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Ingalls & Snyder LLC's AVANIR PHARMACEUTICALS, INC CL A position peaked at $58.1M in Q2 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2015, filed 15 Apr 2015.